PANAGORA ASSET MANAGEMENT INC

Position in HROW — Harrow, Inc.

CIK 883677 Boston, MA

Position in HROW

as of Mar 31, 2026 · filed May 14, 2026 Compact

Position Value

$3,035,780

+$1,133,110 QoQ

Shares Held

86,097

+121.7% QoQ

Ownership

0.231%

of shares outstanding

% of Portfolio

0.01%

of 13F equity value

Holder Rank

—

not a current holder

Holding Since

Sep 2020

9 quarters on record

Voting authority Sole 31.788564061465557.ToString("F0")% Shared 0.ToString("F0")% None 68.21143593853445.ToString("F0")%

Healthcare · as of Mar 31, 2026

PANAGORA ASSET MANAGEMENT INC holds $90,304,727 across 13 Drug Manufacturers - Specialty & Generic names. HROW ranks #5 (3.4% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	ALKS	Alkermes plc.	932,942	$32,988,829
2	UTHR	UNITED THERAPEUTICS Corp	34,953	$20,726,429
3	NBIX	Neurocrine Biosciences Inc	151,449	$19,951,891
4	ELAN	Elanco Animal Health Inc	260,686	$6,238,215
5	HROW	Harrow, Inc. This page	86,097	$3,035,780
6	ADCT	ADC Therapeutics SA	691,275	$2,592,281
7	ZTS	Zoetis Inc.	15,203	$1,797,146
8	BCRX	Biocryst Pharmaceuticals Inc	88,876	$846,099

9 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-03-31	$3,035,780	86,097	+121.7%	Shares	Sole	2026-05-14
2025-12-31	$1,902,670	38,830	-17.6%	Shares	Sole	2026-02-13
2025-06-30	$1,439,411	47,132	+598.3%	Shares	Sole	2025-08-13
2024-12-31	$226,462	6,750	-85.8%	Shares	Sole	2025-02-13
2024-09-30	$2,143,737	47,681	+6326.0%	Shares	Sole	2024-11-13
2021-06-30	$6,893	742	-97.0%	Shares	Sole	2021-08-11
2021-03-31	$169,600	25,126	+2047.5%	Shares	Sole	2021-05-12
2020-12-31	$8,026	1,170	+219.7%	Shares	Sole	2021-02-10
2020-09-30	$2,045	366	—	Shares	Sole	2020-11-13
No filing history on record for this holder in this stock.